• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

17beta-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein.

作者信息

Horiguchi Yuka, Araki Makoto, Motojima Kiyoto

机构信息

Department of Biochemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.

出版信息

Biochem Biophys Res Commun. 2008 May 30;370(2):235-8. doi: 10.1016/j.bbrc.2008.03.063. Epub 2008 Mar 24.

DOI:10.1016/j.bbrc.2008.03.063
PMID:18359291
Abstract

17beta-Hydroxysteroid dehydrogenase (17betaHSD) type 13 is identified as a new lipid droplet-associated protein. 17betaHSD type 13 has an N-terminal sequence similar to that of 17betaHSD type 11, and both sequences function as an endoplasmic reticulum and lipid droplet-targeting signal. Localization of native 17betaHSD type 13 on the lipid droplets was confirmed by subcellular fractionation and Western blotting. In contrast to 17betaHSD type 11, however, expression of 17betaHSD type 13 is largely restricted to the liver and is not enhanced by peroxisome proliferator-activated receptor alpha and its ligand. Instead the expression level of 17betaHSD type 13 in the receptor-null mice was increased several-fold. 17betaHSD type 13 may have a distinct physiological role as a lipid droplet-associated protein in the liver.

摘要

相似文献

1
17beta-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein.
Biochem Biophys Res Commun. 2008 May 30;370(2):235-8. doi: 10.1016/j.bbrc.2008.03.063. Epub 2008 Mar 24.
2
Regulated expression by PPARalpha and unique localization of 17beta-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver.过氧化物酶体增殖物激活受体α(PPARα)对11型17β-羟类固醇脱氢酶蛋白在小鼠肠道和肝脏中的表达调控及独特定位
FEBS J. 2007 Sep;274(18):4837-47. doi: 10.1111/j.1742-4658.2007.06005.x. Epub 2007 Aug 21.
3
Identification and characterization of the ER/lipid droplet-targeting sequence in 17beta-hydroxysteroid dehydrogenase type 11.11型17β-羟基类固醇脱氢酶中内质网/脂滴靶向序列的鉴定与表征
Arch Biochem Biophys. 2008 Nov 15;479(2):121-30. doi: 10.1016/j.abb.2008.08.020. Epub 2008 Sep 10.
4
Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme.一种新型大鼠细胞质17β-羟基类固醇脱氢酶的分子克隆,该酶不同于5型同工酶。
J Biochem. 2006 Jun;139(6):1053-63. doi: 10.1093/jb/mvj109.
5
Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase.一种高度不稳定的人类5型17β-羟基类固醇脱氢酶的特性
Endocrinology. 1999 Feb;140(2):568-74. doi: 10.1210/endo.140.2.6531.
6
Gene expression of 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase in relation to androstenone, testosterone, and estrone sulphate in gonadally intact male and castrated pigs.性腺完整的雄性猪和去势猪中3β-羟基类固醇脱氢酶和17β-羟基类固醇脱氢酶的基因表达与雄烯酮、睾酮和硫酸雌酮的关系
J Anim Sci. 2007 Oct;85(10):2457-63. doi: 10.2527/jas.2007-0087. Epub 2007 Jul 3.
7
Molecular cloning, modeling, and localization of rat type 10 17beta-hydroxysteroid dehydrogenase.大鼠10型17β-羟基类固醇脱氢酶的分子克隆、建模及定位
Mol Cell Endocrinol. 2001 Jan 22;171(1-2):89-98. doi: 10.1016/s0303-7207(00)00391-9.
8
The rat 17beta-hydroxysteroid dehydrogenase type III: molecular cloning and gonadotropin regulation.大鼠Ⅲ型17β-羟基类固醇脱氢酶:分子克隆与促性腺激素调节
Endocrinology. 1999 Aug;140(8):3534-42. doi: 10.1210/endo.140.8.6944.
9
Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme.通过3型17β-羟基类固醇脱氢酶在哺乳动物和非哺乳动物脊椎动物中的雄激素代谢:人类和斑马鱼酶的比较。
J Mol Endocrinol. 2005 Oct;35(2):305-16. doi: 10.1677/jme.1.01853.
10
Intracrine control of estrogen action in human gestational tissues at parturition.分娩时人妊娠组织中雌激素作用的自分泌调控。
J Soc Gynecol Investig. 2004 May;11(4):213-9. doi: 10.1016/j.jsgi.2003.12.003.

引用本文的文献

1
Lipidomic Profiling Reveals HSD17B13 Deficiency-Associated Dysregulated Hepatic Phospholipid Metabolism in Aged Mice.脂质组学分析揭示老年小鼠中与HSD17B13缺乏相关的肝脏磷脂代谢失调
Metabolites. 2025 May 27;15(6):353. doi: 10.3390/metabo15060353.
2
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism.位于11号染色体p11.2区域的非编码调控变异rs2863002通过影响HSD17B12表达和脂质代谢增加神经母细胞瘤风险。
Adv Sci (Weinh). 2025 Sep;12(33):e15181. doi: 10.1002/advs.202415181. Epub 2025 Jun 17.
3
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease.
脂质代谢相关基因的遗传变异和DNA甲基化在代谢功能障碍相关脂肪性肝病中的作用
Front Physiol. 2025 Mar 17;16:1562848. doi: 10.3389/fphys.2025.1562848. eCollection 2025.
4
Hydroxysteroid 17β-dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice.羟基类固醇17β-脱氢酶13(Hsd17b13)基因敲低可减轻高脂饮食肥胖小鼠的肝脏脂肪变性。
Exp Physiol. 2025 Feb 27. doi: 10.1113/EP092535.
5
Identification and validation of Novel Estrogen Biosynthesis Biomarkers in Sinonasal Inverted Papilloma.鼻窦内翻性乳头状瘤中新型雌激素生物合成生物标志物的鉴定与验证
Int J Med Sci. 2025 Jan 1;22(1):158-169. doi: 10.7150/ijms.101753. eCollection 2025.
6
Decoding 17-Beta-hydroxysteroid Dehydrogenase 13: A Multifaceted Perspective on Its Role in Hepatic Steatosis and Associated Disorders.解读17-β-羟基类固醇脱氢酶13:关于其在肝脂肪变性及相关疾病中作用的多方面视角
J Clin Transl Hepatol. 2024 Oct 28;12(10):857-864. doi: 10.14218/JCTH.2024.00257. Epub 2024 Sep 19.
7
Oligonucleotide therapies for nonalcoholic steatohepatitis.用于非酒精性脂肪性肝炎的寡核苷酸疗法。
Mol Ther Nucleic Acids. 2024 Mar 30;35(2):102184. doi: 10.1016/j.omtn.2024.102184. eCollection 2024 Jun 11.
8
Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13.17-β-羟甾脱氢酶 13 定位在脂滴上的结构基础。
Nat Commun. 2023 Aug 24;14(1):5158. doi: 10.1038/s41467-023-40766-0.
9
Characterization of a lipid droplet and endoplasmic reticulum stress related gene risk signature to evaluate the clinical and biological value in hepatocellular carcinoma.鉴定与脂滴和内质网应激相关的基因风险特征,以评估其在肝细胞癌中的临床和生物学价值。
Lipids Health Dis. 2022 Dec 29;21(1):146. doi: 10.1186/s12944-022-01759-y.
10
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD.综述文章:HSD17B13 在非酒精性脂肪性肝病的全球流行病学、自然史、发病机制和治疗中的作用。
Aliment Pharmacol Ther. 2023 Jan;57(1):37-51. doi: 10.1111/apt.17292. Epub 2022 Nov 9.